What question did this study set out to answer?

Assess the role and application of serum troponins as translational biomarkers for identifying drug-induced cardiac injury in safety evaluations.

Serum Troponins as Biomarkers of Drug-Induced Cardiac Toxicity

View Full Paper

Ask AI

Bookmark

Authors

Supports troponin use in drug safety protocols; leaves open need for prospective validation and assay standardization.

Assess the role and application of serum troponins as translational biomarkers for identifying drug-induced cardiac injury in safety evaluations.
Convened an expert working group representing regulatory bodies (FDA), academic institutions, and pharmaceutical safety organizations.
Evaluated preclinical toxicology approaches and clinical pathology data concerning cardiovascular safety monitoring.
Identified serum troponins as highly sensitive and specific circulating indicators of drug-induced myocardial cell injury.
Established consensus recommendations for incorporating cardiac troponin assays into standard preclinical and clinical safety assessment workflows.

Wallace et al. (2004) studied this question.

View Full Paper

Ask AI

Bookmark